Search Results - "Xia, Karen"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    A phase 2a study of toreforant, a histamine H4 receptor antagonist, in eosinophilic asthma by Kollmeier, Alexa P., Barnathan, Elliot S., O'Brien, Christopher, Chen, Bin, Xia, Yichuan (Karen), Zhou, Bei, Loza, Matthew J., Silkoff, Philip E., Ge, Michelle, Thurmond, Robin L.

    Published in Annals of allergy, asthma, & immunology (01-11-2018)
    “…Data from preclinical and clinical studies support the evaluation of histamine 4 receptor antagonists in the treatment of asthma. Toreforant is a selective…”
    Get full text
    Journal Article
  2. 2

    Seasonal impact of regional outdoor biomass burning on air pollution in three Indian cities: Delhi, Bengaluru, and Pune by Liu, Tianjia, Marlier, Miriam E., DeFries, Ruth S., Westervelt, Daniel M., Xia, Karen R., Fiore, Arlene M., Mickley, Loretta J., Cusworth, Daniel H., Milly, George

    Published in Atmospheric environment (1994) (01-01-2018)
    “…Air pollution in many of India's cities exceeds national and international standards, and effective pollution control strategies require knowledge of the…”
    Get full text
    Journal Article
  3. 3

    A phase 2a study of toreforant, a histamine H 4 receptor antagonist, in eosinophilic asthma by Kollmeier, Alexa P, Barnathan, Elliot S, O'Brien, Christopher, Chen, Bin, Xia, Yichuan Karen, Zhou, Bei, Loza, Matthew J, Silkoff, Philip E, Ge, Michelle, Thurmond, Robin L

    Published in Annals of allergy, asthma, & immunology (01-11-2018)
    “…Data from preclinical and clinical studies support the evaluation of histamine 4 receptor antagonists in the treatment of asthma. Toreforant is a selective…”
    Get full text
    Journal Article
  4. 4

    CUTANEOUS TOXICITIES WITH AMIVANTAMAB FOR NON-SMALL CELL LUNG CANCER (NSCLC) WITH EXON 20 INSERTION MUTATION (EX20INS): A PRACTICAL GUIDE AND BEST PRACTICES FOR MANAGEMENT by Singh-Kandah, Shahnaz, Wang, Kaiwen, Xia, Karen, Johnson, Andy, D'Andrea, Denise, Dougherty, Lindsay

    Published in Oncology nursing forum (01-03-2023)
    “…Amivantamab, an EGFR-MET bispecific antibody, is an approved treatment for patients with ex20ins advanced NSCLC post platinum chemotherapy. These patients have…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Cutaneous Toxicities With Amivantamab for Non-Small Cell Lung Cancer: A Practical Guide and Best Practices by Singh-Kandah, Shahnaz, Wang, Kaiwen, Xia, Karen, Lain Johnson, Andy, D'Andrea, Denise M, Shu, Catherine A, Bray Dougherty, Lindsay, Gallitano, Stephanie M

    Published in Clinical journal of oncology nursing (01-10-2024)
    “…Amivantamab is an epidermal growth factor receptor (EGFR) and MET bispecific antibody approved for certain patients with advanced non-small cell lung cancer…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Seasonal Impact of Regional Outdoor Biomass Burning on Air Pollution in Three Indian Cities: Delhi, Bengaluru, and Pune by Liu, Tianjia, Marlier, Miriam E., DeFries, Ruth S., Westervelt, Daniel M., Xia, Karen R., Fiore, Arlene M., Mickley, Loretta J., Cusworth, Daniel H., Milly, George

    Published in Atmospheric environment (1994) (02-11-2017)
    “…Air pollution in many of India's cities exceeds national and international standards, and effective pollution control strategies require knowledge of the…”
    Get full text
    Journal Article
  9. 9

    Dexamethasone Reduces IL-17 and Tim-3 Expression in BALF of Asthmatic Mice by Lu, Xiao-xia, McCoy, Karen S., Hu, Wei-kun, Xu, Jia-li, Wang, Hai-qin, Chen, Peng, Chen, He-bin

    “…Summary: This study investigated the expression of interleukin-17 (IL-17) and T cell immunoglobulin mucin and domain-containing molecule-3 (Tim-3) in…”
    Get full text
    Journal Article